SAMDaily.us | AWARD | A | Clinical Development of VE303, a Live Biotherapeutic Product (LBP) for Prevention of Recurrent C. difficile Infection and Treatment of Antibiotic-Induced Dysbiosis

SAMDAILY.US - ISSUE OF OCTOBER 01, 2020 SAM #6881
AWARD

A -- Clinical Development of VE303, a Live Biotherapeutic Product (LBP) for Prevention of Recurrent C. difficile Infection and Treatment of Antibiotic-Induced Dysbiosis

Notice Date: 9/29/2020 10:47:20 AM
Notice Type: Award Notice
NAICS: 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
Contracting Office: OFFICE OF ACQ MGMT POLICY WASHINGTON DC 20201 USA
ZIP Code: 20201
Solicitation Number: BAA-18-100-SOL-00003
Archive Date: 10/13/2020
Point of Contact: Rosa Lopez, Phone: 202-595-4991, Jeanette Evans-Gray, Phone: 202-692-4688
E-Mail Address: Rosa.Lopez@hhs.gov, Doris.Evans-Gray@hhs.gov
(Rosa.Lopez@hhs.gov, Doris.Evans-Gray@hhs.gov)
Award Number: 75A50120C00177
Award Date: 09/28/2020
Awardee: VEDANTA BIOSCIENCES, INC. Boston MA USA
Award Amount: 76943067.00
Description: This a competivitely awarded cost share contract.� The Government's total cost share is $76,943,067.
Web Link: SAM.gov Permalink
(https://beta.sam.gov/opp/95fd7d06eab04a40bb40282a3ed43244/view)
Place of Performance: Address: Boston, MA 02116, USA; Zip Code: 02116; Country: USA
Record: SN05813399-F 20201001/200929230148 (samdaily.us)
Source: SAM.gov Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's SAM Daily Index Page |